Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000326953 | SCV000359531 | uncertain significance | Stargardt Disease, Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000383912 | SCV000359532 | uncertain significance | Retinitis Pigmentosa, Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000292103 | SCV000359533 | uncertain significance | Macular degeneration | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000339971 | SCV000359534 | uncertain significance | Cone-Rod Dystrophy, Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000907632 | SCV000511882 | likely benign | not provided | 2018-09-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000907632 | SCV001052348 | likely benign | not provided | 2024-10-26 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV001075141 | SCV001240752 | uncertain significance | Retinal dystrophy | 2018-09-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004537688 | SCV004746915 | likely benign | ABCA4-related disorder | 2020-01-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |